Take-Two Interactive Software, Inc. (BMV:TTWO)
Mexico · Delayed Price · Currency is MXN 4,345.00
+145.00 (3.45%)
At close: Aug 8, 2025, 2:00 PM CST
Ligand Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
| 5,799 | 5,634 | 5,350 | 5,350 | 3,505 | 3,373 | Upgrade | |
Revenue Growth (YoY) | 7.33% | 5.31% | -0.01% | 52.64% | 3.91% | 9.19% | Upgrade |
Cost of Revenue | 2,349 | 2,357 | 2,421 | 2,520 | 1,465 | 1,496 | Upgrade |
Gross Profit | 3,451 | 3,277 | 2,929 | 2,830 | 2,040 | 1,877 | Upgrade |
Selling, General & Admin | 2,507 | 2,533 | 2,266 | 2,396 | 1,027 | 835.4 | Upgrade |
Research & Development | 1,047 | 1,005 | 948.2 | 887.6 | 406.6 | 317.3 | Upgrade |
Operating Expenses | 3,749 | 3,728 | 3,386 | 3,406 | 1,495 | 1,208 | Upgrade |
Operating Income | -298.5 | -451.3 | -456.6 | -576.2 | 545 | 668.5 | Upgrade |
Interest Expense | -176.2 | -174.1 | -147.5 | -129.6 | -18.6 | -6.2 | Upgrade |
Interest & Investment Income | 98.6 | 98.6 | 62.3 | 33.8 | 17.6 | 18.7 | Upgrade |
Currency Exchange Gain (Loss) | -44.2 | -22.6 | -28.6 | -31.8 | -7.3 | 0.7 | Upgrade |
Other Non Operating Income (Expenses) | 13.5 | -2.1 | -6.1 | -45.3 | 0.1 | -4.4 | Upgrade |
EBT Excluding Unusual Items | -406.8 | -551.5 | -576.5 | -749.1 | 536.8 | 677.3 | Upgrade |
Merger & Restructuring Charges | -83.2 | -136.9 | -104.6 | -14.6 | -0.8 | - | Upgrade |
Impairment of Goodwill | -3,545 | -3,545 | -2,342 | - | - | - | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 39.6 | Upgrade |
Asset Writedown | -257.7 | -257.7 | -687.3 | -574.4 | -70.6 | -39.1 | Upgrade |
Other Unusual Items | - | - | 7.7 | - | - | - | Upgrade |
Pretax Income | -4,293 | -4,491 | -3,703 | -1,338 | 465.4 | 677.8 | Upgrade |
Income Tax Expense | -64.1 | -12.4 | 41.4 | -213.4 | 47.4 | 88.9 | Upgrade |
Net Income | -4,229 | -4,479 | -3,744 | -1,125 | 418 | 588.9 | Upgrade |
Net Income to Common | -4,229 | -4,479 | -3,744 | -1,125 | 418 | 588.9 | Upgrade |
Net Income Growth | - | - | - | - | -29.02% | 45.60% | Upgrade |
Shares Outstanding (Basic) | 177 | 175 | 170 | 160 | 116 | 115 | Upgrade |
Shares Outstanding (Diluted) | 177 | 175 | 170 | 160 | 117 | 116 | Upgrade |
Shares Change (YoY) | 3.75% | 2.94% | 6.38% | 36.90% | 0.95% | 1.37% | Upgrade |
EPS (Basic) | -23.86 | -25.58 | -22.01 | -7.03 | 3.62 | 5.14 | Upgrade |
EPS (Diluted) | -23.86 | -25.58 | -22.01 | -7.03 | 3.58 | 5.09 | Upgrade |
EPS Growth | - | - | - | - | -29.67% | 43.79% | Upgrade |
Free Cash Flow | -58.3 | -214.6 | -157.8 | -203.1 | 99.4 | 843.4 | Upgrade |
Free Cash Flow Per Share | -0.33 | -1.23 | -0.93 | -1.27 | 0.85 | 7.29 | Upgrade |
Gross Margin | 59.50% | 58.16% | 54.75% | 52.89% | 58.21% | 55.65% | Upgrade |
Operating Margin | -5.15% | -8.01% | -8.54% | -10.77% | 15.55% | 19.82% | Upgrade |
Profit Margin | -72.92% | -79.50% | -69.99% | -21.02% | 11.93% | 17.46% | Upgrade |
Free Cash Flow Margin | -1.00% | -3.81% | -2.95% | -3.80% | 2.84% | 25.01% | Upgrade |
EBITDA | 600.7 | 448.9 | 520.4 | 555.5 | 671 | 757 | Upgrade |
EBITDA Margin | 10.36% | 7.97% | 9.73% | 10.38% | 19.14% | 22.44% | Upgrade |
D&A For EBITDA | 899.2 | 900.2 | 977 | 1,132 | 126 | 88.5 | Upgrade |
EBIT | -298.5 | -451.3 | -456.6 | -576.2 | 545 | 668.5 | Upgrade |
EBIT Margin | -5.15% | -8.01% | -8.54% | -10.77% | 15.55% | 19.82% | Upgrade |
Effective Tax Rate | - | - | - | - | 10.18% | 13.12% | Upgrade |
Revenue as Reported | 5,799 | 5,634 | 5,350 | 5,350 | 3,505 | 3,373 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.